4//SEC Filing
MacDougall Ann L. 4
Accession 0001385508-21-000070
CIK 0001385508other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:06 PM ET
Size
7.4 KB
Accession
0001385508-21-000070
Insider Transaction Report
Form 4
MacDougall Ann L.
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-05-13$10.00/sh−341$3,410→ 0 totalExercise: $10.00Exp: 2021-05-16→ Common Stock (341 underlying) - Exercise/Conversion
Common Stock
2021-05-13$10.00/sh+341$3,410→ 21,179 total
Footnotes (1)
- [F1]On May 17, 2016, the reporting person was granted an option to purchase 35,000 shares of Common Stock. The options vest as follows: (i) 11,667 share upon the up listing of the Issuer to The NASDAQ Stock Market (which occurred on August 29, 2017); (ii) 11,667 shares upon the cumulative funding of the Issuer in excess of $5,000,000 by institutional investors, commencing May 5, 2016 (which performance criteria was met on December 13, 2016); and (iii) 11,666 shares upon the first submission of a New Drug Application ("NDA") to the FDA for one of Issuer's products by either the Issuer or an Issuer licensee.
Documents
Issuer
OPIANT PHARMACEUTICALS, INC.
CIK 0001385508
Entity typeother
Related Parties
1- filerCIK 0001685788
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 4:06 PM ET
- Size
- 7.4 KB